Ilyang Pharmaceutical Co.,Ltd (007570.KS) KSC

Currency In KRW

AD

Valuation

Market Cap254.88B
Enterprise Value358.02B
P/E Ratio7.16
PEG Ratio0.08
Price/Sales Ratio0.55
Price/Book Ratio0.56
Enterprise/Revenue0.83
Enterprise/EBITDA90.44

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin-0.02
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue272.24B
Revenue/Share16,337.12
Gross Profit116.35B
EBITDA13.31B
Net Income6.9B
Diluted EPS375.42

Balance Sheet

Total Cash38.79B
Total Cash/Share2,301.39
Total Debt112.65B
Total Debt/Equity0.44
Current Ratio0.96
Book Value Per Share15,280.95

Price History

52-Week Change-39.93
52-Week High16,240
52-Week Low7,290
Moving Average 50 Days8,926.6
Moving Average 200 Days11,884.1

Statistics

Average Volume72,746
Shares Outstanding17.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate155
Trailing Annual Dividend Yield1.84
Payout Ratio0.16
Last Split Factor131:125
Last Split DateMarch 04, 2011
AD